Sweet's syndrome with panuveitis resembling Behçet's disease

被引：0
作者：
Wataru Matsumiya
Sentaro Kusuhara
Yozo Yamada
Atsushi Azumi
Akira Negi
机构：
[1] Kobe University Graduate School of Medicine,Division of Ophthalmology, Department of Surgery
[2] Kobe University Graduate School of Medicine,Division of Dermatology, Department of Internal Related
[3] Kobe Kaisei Hospital,Department of Ophthalmology
来源：
Japanese Journal of Ophthalmology | 2012年 / 56卷
关键词：
Sweet's syndrome; Uveitis; Behçet's disease; HLA antigen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：268 / 272
页数：4
相关论文
共 50 条
[21]   Serum amyloid-A in Behçet’s disease [J].
Antonio Vitale ;
Donato Rigante ;
Giuseppe Lopalco ;
Maria Giuseppina Brizi ;
Francesco Caso ;
Rossella Franceschini ;
Rosario Denaro ;
Mauro Galeazzi ;
Leonardo Punzi ;
Florenzo Iannone ;
Giovanni Lapadula ;
Antonella Simpatico ;
Edoardo Marrani ;
Luisa Costa ;
Rolando Cimaz ;
Luca Cantarini .
Clinical Rheumatology, 2014, 33 :1165-1167
[22]   Spectrum of Behçet's disease in the Indian population [J].
Sachdev N. ;
Kapali N. ;
Singh R. ;
Gupta V. ;
Gupta A. .
International Ophthalmology, 2009, 29 (6) :495-501
[23]   Behçet's syndrome: one year in review 2023 [J].
Hatemi, G. ;
Seyahi, E. ;
Fresko, I. ;
Talarico, R. ;
Ucar, D. ;
Hamuryudan, V. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (10) :1945-1954
[24]   Potential New Therapeutic Options in Behçet’s Syndrome [J].
Andrew I. Russell ;
Wendy A. Lawson ;
Dorian O. Haskard .
BioDrugs, 2001, 15 :25-35
[25]   Ocular Involvement of Behçet’s Syndrome: a Comprehensive Review [J].
Yilmaz Ozyazgan ;
Didar Ucar ;
Gulen Hatemi ;
Yusuf Yazici .
Clinical Reviews in Allergy & Immunology, 2015, 49 :298-306
[26]   Tocilizumab for refractory Castleman’s disease with paraneoplastic pemphigus and Behçet’s disease [J].
Ana Beatriz Vargas ;
Beatriz M Trope ;
Blanca ERG Bica .
Pediatric Rheumatology, 10 (Suppl 1)
[27]   Sweet's syndrome in Behcet's disease [J].
Hassikou, Hasna ;
Tabache, Fatima ;
Baaj, Mohamed ;
Safi, Soumaya ;
Hadri, Larbi .
JOINT BONE SPINE, 2007, 74 (05) :495-496
[28]   Choose pharmacological therapy for Behçet's syndrome based on disease severity and organ involvement [J].
Adis Medical Writers .
Drugs & Therapy Perspectives, 2013, 29 (6) :171-175
[29]   Serum vitronectin levels in patients with Behçet’s disease [J].
Ali Yalçındağ ;
Aslıhan Uzun ;
F. Nilüfer Yalçındağ ;
Namık Delibaş .
Inflammation Research, 2012, 61 :1241-1246
[30]   Behçet's disease: from innate to adaptive immunity [J].
H Direskeneli .
Arthritis Res Ther, 5
12345